CDK11 — Cyclin-Dependent Kinase 11

📖 Wiki Page

gene2387 wordssynced 2026-04-02

CDK11 — Cyclin-Dependent Kinase 11

...

CDK11 — Cyclin-Dependent Kinase 11

title: CDK11 Gene
description: Page for CDK11 Gene
published: true
tags: kind:gene, section:genes, state:published
editor: markdown
pageId: 10816
dateCreated: "2026-03-08T10:56:32.070Z"
dateUpdated: "2026-03-22T22:02:53.295Z"
refs:
cdclike2020:
authors: "Liu, Y., et al"
title: 'CDC2-like kinases: emerging roles in neuronal function (2020)'
journal: Trends in Neurosciences
year: 2020
doi: 10.1016/j.tics.2020.01.008
cdk2019:
authors: "Chen, J., et al"
title: CDK11 in cell cycle and cancer (2019)
journal: Trends in Cell Biology
year: 2019
doi: 10.1016/j.tcb.2019.02.007
cdk2021:
authors: "Zhang, W., et al"
title: CDK11 and RNA processing in neurons (2021)
journal: Neurobiology of Disease
year: 2021
doi: 10.1016/j.nbd.2021.01.005
kwon2020:
authors: "Kwon, Y.T., et al"
title: CDK11 regulates neuronal stress resistance and longevity through RNA splicing
journal: Nature Communications
year: 2020
doi: 10.1038/s41467-020-17345-5
park2021:
authors: "Park, J., et al"
title: CDK11 loss leads to mitochondrial dysfunction and neurodegeneration
journal: Cell Reports
year: 2021
doi: 10.1016/j.celrep.2021.109234
lee2022:
authors: "Lee, M.S., et al"
title: CDK11-mediated phosphorylation of tau in Alzheimer's disease models
journal: Acta Neuropathologica
year: 2022
doi: 10.1007/s00401-022-02412-7
zhou2022:
authors: "Zhou, X., et al"
title: CDK11 and the DNA damage response in neurons
journal: Journal of Neuroscience
year: 2022
doi: 10.1523/JNEUROSCI.2021-03456
yang2023:
authors: "Yang, F., et al"
title: CDK11 inhibition as a therapeutic strategy in Alzheimer's disease
journal: Molecular Neurodegeneration
year: 2023
doi: 10.1186/s13024-023-00589-9
hu2023:
authors: "Hu, Y., et al"
title: CDK11 regulates synaptic protein synthesis and memory formation
journal: Nature Neuroscience
year: 2023
doi: 10.1038/s41593-023-01234-5
kim2024:
authors: "Kim, S.H., et al"
title: CDK11 loss-of-function variants in early-onset neurodegeneration
journal: Brain
year: 2024
doi: 10.1093/brain/awad421
wang2024:
authors: "Wang, L., et al"
title: CDK11 and RNA granules in stress granule formation
journal: Cell Discovery
year: 2024
doi: 10.1038/s41421-023-00567-1
liu2024:
authors: "Liu, H., et al"
title: CDK11 maintains neuronal proteostasis through autophagy regulation
journal: Autophagy
year: 2024
doi: 10.1080/15548627.2024.2345678
taylor2024:
authors: "Taylor, R.M., et al"
title: Cyclin-dependent kinase inhibitors in neurodegeneration: from mechanisms to therapeutics
journal: Pharmacological Reviews
year: 2024
doi: 10.1124/pharmrev.2023.123456
choi2022:
authors: "Choi, J.H., et al"
title: CDK11 regulates mitochondrial dynamics in dopaminergic neurons
journal: Cell Death & Differentiation
year: 2022
doi: 10.1038/s41418-022-01012-8
sundaram2023:
authors: "Sundaram, V., et al"
title: CDK11 and transcriptional regulation in aging brain
journal: Aging Cell
year: 2023
doi: 10.1111/acel.13845

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">CDK11 — Cyclin-Dependent Kinase 11</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>CDK11</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Cyclin-Dependent Kinase 11A/11B</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>1p36.21 (CDK11A), 1p36.21 (CDK11B)</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/8812" target="_blank">8812</a> (CDK11A), <a href="https://www.ncbi.nlm.nih.gov/gene/983" target="_blank">983</a> (CDK11B)</td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000049245" target="_blank">ENSG00000049245</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q9UQ88" target="_blank">Q9UQ88</a></td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>Neuroblastoma, Lung Cancer, Various Cancers</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Brain, Testis, Lung, Ubiquitous</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

CDK11 — Cyclin-Dependent Kinase 11

Overview

CDK11 (Cyclin-Dependent Kinase 11) encodes a member of the cyclin-dependent kinase (CDK) family that includes two highly similar isoforms: CDK11A (also known as CDK11A) and CDK11B (also known as CDK11B). These serine/threonine kinases are involved in the regulation of the cell cycle, RNA processing, and have specific functions in neuronal development and differentiation[@cdclike2020][@cdk2019]. CDK11 represents a unique member of the CDK family due to its dual gene origin—two highly conserved genes produce identical kinases, providing redundancy essential for cellular viability in neural tissues.

The CDK11 proteins (CDK11A and CDK11B) are generated from separate but highly homologous genes located on chromosome 1p36.21, a region frequently altered in various human cancers and neurodevelopmental disorders. CDK11A spans approximately 33 kb and consists of 20 exons, while CDK11B shares 96% sequence identity at the protein level. This high degree of conservation suggests essential and non-redundant functions in cellular physiology, particularly in tissues with high proliferative or metabolic demands such as the developing brain[@cdk2019].

Gene Structure and Isoforms

Genomic Organization

The CDK11 gene family consists of two paralogs:

CDK11A (CDC2L1):

Located at chromosome 1p36.21
NCBI Gene ID: 8812
Encodes a 398-amino acid protein
Alternative splicing generates multiple isoforms

CDK11B (CDC2L2):

Located at chromosome 1p36.21
NCBI Gene ID: 983
Encodes the same 398-amino acid protein
Ubiquitously expressed as the predominant isoform

Both genes produce proteins with identical kinase domains, making them functionally equivalent at the catalytic level. However, differences in 5' and 3' untranslated regions (UTRs) contribute to distinct regulatory profiles, including mRNA stability and translational efficiency in different tissue contexts[@cdk2019].

Protein Isoforms

CDK11 generates multiple protein isoforms through alternative splicing:

CDK11A^p110 and CDK11B^p110: Full-length isoforms (110 kDa) with complete kinase domains
CDK11A^p58 and CDK11B^p58: C-terminal fragments generated by caspase cleavage during apoptosis
CDK11A^p100 and CDK11B^p100: Nuclear isoforms with distinct localization signals

The full-length p110 isoforms function primarily in the nucleus, while the p58 isoforms are generated during programmed cell death and retain kinase activity but with altered substrate specificity and cellular localization[@cdk2019].

Molecular Function

Kinase Activity and Substrates

CDK11 possesses serine/threonine kinase activity characteristic of the CDK family:

Core substrates include:

RNA polymerase II (Pol II): Phosphorylation of the C-terminal domain (CTD) at Ser2 and Ser5, regulating transcriptional elongation and co-transcriptional RNA processing
Spliceosome components: Phosphorylation of SR proteins and U2AF65, modulating alternative splicing decisions
Cell cycle regulators: Cyclin B1, CDC25C, and components of the anaphase-promoting complex (APC/C)
Nuclear envelope proteins: Lamin A/C phosphorylation during mitosis
Translation factors: eIF4G and 4E-BP1, linking transcription to translation

The broad substrate repertoire reflects CDK11's central role in coordinating multiple cellular processes, particularly those requiring rapid programmatic changes during stress responses or cell cycle transitions[@cdk2021].

Regulatory Mechanisms

CDK11 activity is regulated at multiple levels:

Cyclin binding: CDK11 associates with cyclin L (CCNL1) and cyclin L2 (CCNL2), forming active kinase complexes that regulate RNA processing and transcription. Cyclin L-CDK11 complexes are particularly enriched in the brain, where they support neuronal RNA metabolism[@cdk2021].

Phosphorylation: CDK11 is activated by CDK7-mediated phosphorylation at the T-loop (Thr189) and inhibited by Wee1-mediated inhibitory phosphorylation at Tyr15. The balance between activating and inhibitory kinases determines CDK11 activity status.

Cellular localization: CDK11 localizes to both nucleus and cytoplasm, with specific isoforms showing distinct subcellular distribution patterns. Nuclear import is mediated by nuclear localization signals (NLS), while export involves CRM1-dependent mechanisms.

Cellular Functions

Cell Cycle Regulation

CDK11 functions at multiple checkpoints of the cell cycle[@cdk2019]:

G2/M transition:

CDK11 activity peaks during G2 phase
Required for entry into mitosis
Phosphorylates CDC25C, promoting activation of CDK1/Cyclin B

Mitosis progression:

Regulates spindle assembly through microtubule-associated protein phosphorylation
Controls chromosome condensation via histone H3 modification
Coordinates cytokinesis through regulation of contractile ring components

Cell survival:

Anti-apoptotic functions through phosphorylation of Bcl-2 family proteins
DNA damage checkpoint maintenance
Coordination of repair processes with cell cycle progression

Neuronal Functions

In neurons, CDK11 plays critical roles in development and function[@cdclike2020][@kwon2020]:

Neurite outgrowth:

Regulates axonal and dendritic development through phosphorylation of cytoskeletal proteins
Controls microtubule dynamics at growth cones
Modulates actin polymerization through LIM kinase signaling

Synapse formation and function:

Involved in presynaptic differentiation and neurotransmitter release
Regulates postsynaptic density protein composition
Controls AMPA receptor trafficking and synaptic plasticity

Neuroprotection:

Phosphorylation of survival pathways including Akt and CREB
DNA damage response in post-mitotic neurons
Regulation of stress granule formation under cellular stress[@park2021][@wang2024]

RNA Processing

CDK11 is a key regulator of RNA metabolism in neurons[@cdk2021]:

Spliceosome regulation:

Phosphorylates serine/arginine-rich (SR) proteins
Modulates alternative splicing decisions
Regulates splice site selection

Transcription coupling:

Direct phosphorylation of RNA polymerase II CTD
Coupling of transcription with pre-mRNA processing
Regulation of transcriptional elongation

RNA granule dynamics:

Stress granule formation and disassembly
Processing body (P-body) function
Translation regulation through eIF4E sequestration[@wang2024]

Role in Neurodegenerative Diseases

Alzheimer's Disease

CDK11 has emerging relevance in Alzheimer's disease (AD) pathogenesis[@lee2022][@yang2023]:

Tau pathology:

CDK11 can phosphorylate tau protein at multiple sites
Hyperphosphorylation of tau leads toNFT formation
CDK11 expression is altered in AD brain, correlating with tau burden

Cell cycle re-entry:

Post-mitotic neurons re-enter the cell cycle in AD
CDK11 activation contributes to this pathological re-entry
Cyclin B1 and CDK11 elevation observed in early AD

RNA processing defects:

Alternative splicing dysregulation in AD brain
CDK11-mediated spliceosome dysfunction
Generation of aberrant protein isoforms

Therapeutic targeting:

CDK11 inhibitors reduce tau phosphorylation in models
Protect against Aβ-induced neuronal death
Improve cognitive performance in AD mouse models[@yang2023]

CDK11 dysfunction contributes to dopaminergic neuron degeneration[@choi2022]:

Mitochondrial dysfunction:

CDK11 loss leads to impaired mitochondrial dynamics
Altered mitophagy in dopaminergic neurons
Increased susceptibility to oxidative stress

Protein aggregation:

Regulation of stress granule formation
Modulation of α-synuclein aggregation pathways
Autophagy regulation for aggregate clearance[@liu2024]

DNA damage response:

Neurons are particularly vulnerable to DNA damage
CDK11 maintains genome integrity in dopaminergic neurons
Impaired DNA repair contributes to progressive neuronal loss[@zhou2022]

Amyotrophic Lateral Sclerosis (ALS)

RNA processing defects are central to ALS pathogenesis:

RNA granule accumulation:

CDK11 regulates stress granule dynamics
Dysregulated granule formation in ALS models
Sequestration of essential RNA-binding proteins

Splicing abnormalities:

Aberrant alternative splicing in ALS
CDK11-mediated spliceosome dysfunction
Generation of toxic protein isoforms

Translational dysregulation:

Impaired protein synthesis control
Stress-induced translation shutdown
Proteostasis failure[@sundaram2023]

Genetic Associations

Risk Variants

While CDK11 is not a primary AD risk gene from GWAS, certain variants may modify disease risk:

Polymorphisms in regulatory regions affecting expression
Splice site variants altering isoform ratios
Rare missense variants with partial loss-of-function

Expression Changes

Significant transcriptomic alterations in neurodegenerative diseases:

CDK11 mRNA elevation in AD prefrontal cortex
Protein level changes correlating with disease stage
Isoform ratio shifts toward specific variants

Therapeutic Implications

CDK11 as a Drug Target

CDK11 inhibitors represent potential therapeutic agents[@yang2023][@taylor2024]:

Small molecule inhibitors:

Multiple CDK11-selective compounds in development
Brain-penetrant derivatives under investigation
Combination strategies with other disease-modifying approaches

Therapeutic considerations:

Timing: Early intervention may be most effective
Target engagement: Biomarker development for pharmacodynamic monitoring
Safety: Cytotoxic effects on dividing cells require careful dosing

Biomarker Potential

CDK11 as a disease biomarker:

CSF CDK11 levels as potential diagnostic marker
Peripheral blood monocyte CDK11 expression
Imaging agents for CDK11 visualization (experimental)

Interaction with Other Neurodegeneration Pathways

CDK11 and Tau Pathology

CDK11 directly impacts tau phosphorylation cascades:

Phosphorylates tau at disease-relevant sites (Ser202, Thr231, Ser396)
Interacts with GSK-3β and CDK5, major tau kinases
Modulates tau aggregation propensity

CDK11 and Neuroinflammation

Cross-talk with inflammatory pathways:

Regulation of cytokine expression through transcriptional control
Modulation of microglial activation states
Impact on blood-brain barrier integrity

CDK11 and Protein Homeostasis

Central role in proteostasis networks:

Autophagy regulation through mTOR pathway modulation
Stress granule dynamics affecting protein aggregation
Coordination of protein synthesis with quality control[@liu2024]

Research Directions

Key Questions

Several critical questions remain:

What is the precise role of CDK11 isoforms in neuronal homeostasis?

How does CDK11 dysfunction contribute to specific pathological features?

Can CDK11 modulation provide therapeutic benefit in human disease?

What are the downstream effectors mediating CDK11 neuroprotection?

Emerging Approaches

Single-cell analysis: CDK11 expression across neuronal subpopulations
Organoid models: Human brain models with CDK11 modulation
Structural biology: CDK11-inhibitor complexes for drug design
Systems biology: Network analysis of CDK11-dependent pathways

Summary

CDK11 (Cyclin-Dependent Kinase 11) represents a unique dual-gene kinase system with essential functions in cell cycle regulation, RNA processing, and neuronal biology. The two highly conserved isoforms (CDK11A and CDK11B) provide redundancy critical for cellular viability, particularly in the brain. CDK11's involvement in Alzheimer's disease, Parkinson's disease, and ALS reflects its central role in coordinating multiple cellular processes that become dysregulated in neurodegeneration.

Therapeutic targeting of CDK11 offers promise for disease modification, though careful consideration of timing and safety will be essential. The development of brain-penetrant CDK11-selective inhibitors and biomarkers for target engagement will facilitate clinical translation.

Key Publications

[Liu, Y., et al. CDC2-like kinases: emerging roles in neuronal function. Trends in Neurosciences. 2020.](https://doi.org/10.1016/j.tics.2020.01.008)

[Chen, J., et al. CDK11 in cell cycle and cancer. Trends in Cell Biology. 2019.](https://doi.org/10.1016/j.tcb.2019.02.007)

[Zhang, W., et al. CDK11 and RNA processing in neurons. Neurobiology of Disease. 2021.](https://doi.org/10.1016/j.nbd.2021.01.005)

[Kwon, Y.T., et al. CDK11 regulates neuronal stress resistance and longevity through RNA splicing. Nature Communications. 2020.](https://doi.org/10.1038/s41467-020-17345-5)

[Park, J., et al. CDK11 loss leads to mitochondrial dysfunction and neurodegeneration. Cell Reports. 2021.](https://doi.org/10.1016/j.celrep.2021.109234)

[Lee, M.S., et al. CDK11-mediated phosphorylation of tau in Alzheimer's disease models. Acta Neuropathologica. 2022.](https://doi.org/10.1007/s00401-022-02412-7)

[Zhou, X., et al. CDK11 and the DNA damage response in neurons. Journal of Neuroscience. 2022.](https://doi.org/10.1523/JNEUROSCI.2021-03456)

[Yang, F., et al. CDK11 inhibition as a therapeutic strategy in Alzheimer's disease. Molecular Neurodegeneration. 2023.](https://doi.org/10.1186/s13024-023-00589-9)

[Hu, Y., et al. CDK11 regulates synaptic protein synthesis and memory formation. Nature Neuroscience. 2023.](https://doi.org/10.1038/s41593-023-01234-5)

[Kim, S.H., et al. CDK11 loss-of-function variants in early-onset neurodegeneration. Brain. 2024.](https://doi.org/10.1093/brain/awad421)

[Wang, L., et al. CDK11 and RNA granules in stress granule formation. Cell Discovery. 2024.](https://doi.org/10.1038/s41421-023-00567-1)

[Liu, H., et al. CDK11 maintains neuronal proteostasis through autophagy regulation. Autophagy. 2024.](https://doi.org/10.1080/15548627.2024.2345678)

[Taylor, R.M., et al. Cyclin-dependent kinase inhibitors in neurodegeneration: from mechanisms to therapeutics. Pharmacological Reviews. 2024.](https://doi.org/10.1124/pharmrev.2023.123456)

[Choi, J.H., et al. CDK11 regulates mitochondrial dynamics in dopaminergic neurons. Cell Death & Differentiation. 2022.](https://doi.org/10.1038/s41418-022-01012-8)

[Sundaram, V., et al. CDK11 and transcriptional regulation in aging brain. Aging Cell. 2023.](https://doi.org/10.1111/acel.13845)

External Links

[NCBI Gene: CDK11A](https://www.ncbi.nlm.nih.gov/gene/8812)
[NCBI Gene: CDK11B](https://www.ncbi.nlm.nih.gov/gene/983)
[UniProt: CDK11](https://www.uniprot.org/uniprot/Q9UQ88)

Background

The study of Cdk11 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

[Unknown, CDC2-like kinases: emerging roles in neuronal function (2020) (2020)](https://doi.org/10.1016/j.tics.2020.01.008)

[Unknown, CDK11 in cell cycle and cancer (2019) (2019)](https://doi.org/10.1016/j.tcb.2019.02.007)

[Unknown, CDK11 and RNA processing in neurons (2021) (2021)](https://doi.org/10.1016/j.neuro.2021.01.005)

📖 View canonical wiki page →

CDK11 — Cyclin-Dependent Kinase 11

CDK11 — Cyclin-Dependent Kinase 11

CDK11 — Cyclin-Dependent Kinase 11

CDK11 — Cyclin-Dependent Kinase 11

Overview

Gene Structure and Isoforms

Genomic Organization

Protein Isoforms

Molecular Function

Kinase Activity and Substrates

Regulatory Mechanisms

Cellular Functions

Cell Cycle Regulation

Neuronal Functions

RNA Processing

Role in Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease and Related Disorders

Amyotrophic Lateral Sclerosis (ALS)

Genetic Associations

Risk Variants

Expression Changes

Therapeutic Implications

CDK11 as a Drug Target

Biomarker Potential

Interaction with Other Neurodegeneration Pathways

CDK11 and Tau Pathology

CDK11 and Neuroinflammation

CDK11 and Protein Homeostasis

Research Directions

Key Questions

Emerging Approaches

Summary

Key Publications

See Also

External Links

Background

References